Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
ZNTL holding history
Zentalis Pharmaceuticals, Inc. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZNTL overviewAll 13F holders of ZNTLFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −17,503−100.0% | Sold out | Holders |
| Q1 2026 | 17,503 | $41.0K | <0.1% | +503+3.0% | Added | Holders |
| Q4 2025 | 17,000 | $22.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 17,000 | $25.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 17,000 | $19.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 17,000 | $27.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 17,000 | $51.5K | <0.1% | +1,000+6.3% | Added | Holders |
| Q3 2024 | 16,000 | $58.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 16,000 | $65.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 16,000 | $252.2K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2023 | 16,000 | $242.4K | 0.2% | +16,000 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −8,000−100.0% | Sold out | Holders |
| Q2 2022 | 8,000 | $225.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2022 | 8,000 | $369.0K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2021 | 8,000 | $672.0K | 0.4% | 00.0% | Unchanged | Holders |
| Q3 2021 | 8,000 | $533.0K | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2021 | 8,000 | $426.0K | 0.3% | +8,000 | New | Holders |